From: Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
HCV Genotypes
Treatment type
IFNα & RBV
(%)
PegIFN & RBV
3a
78(90.6)
33 (66)
3b
None
1 (2)
1a
1 (1.2)
5 (10)
3a/1a
4 (8)
3a/1b
2 (4)
2b
1 (.7)
none
Untypable
6 (6.9)
Total
86
50